Institute of Metabolic Science, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Diabet Med. 2014 May;31(5):595-9. doi: 10.1111/dme.12346. Epub 2013 Nov 18.
To examine the association between lung function and metabolic syndrome/Type 2 diabetes.
A total of 1454 adults from rural Victoria, Australia, from randomly selected households included in the Crossroads study, provided spirometric measurements including forced vital capacity, forced expiratory volume in 1 s, predicted percentage value of forced expiratory volume in 1 s and forced vital capacity predicted percentage value. Assessments also included HbA(1c), metabolic syndrome components and a 75-g oral glucose tolerance test. The area under the receiver-operating characteristic curves for waist circumference were compared with those for combinations of waist circumference and raw spirometric measures (forced vital capacity and forced expiratory volume in 1 s) for identifying metabolic syndrome or Type 2 diabetes.
Partipants with a greater number of metabolic syndrome components were more likely to have reduced lung function, particularly if Type 2 diabetes was present: the predicted value of forced expiratory volume in 1 s decreased by 5-6% for participants with 2-4 metabolic syndrome components, and by 9% for those with Type 2 diabetes. The risk of metabolic syndrome or Type 2 diabetes was inversely associated with higher spirometry values (forced expiratory volume in 1 s percentage predicted value: odds ratio for 2-4 metabolic syndrome components 0.36-0.21 in women and 0.32-0.30 men; the odds ratio for Type 2 diabetes was 0.36 in women and 0.28 in men). Receiver-operating characteristic curve analysis for identifying metabolic syndrome and Type 2 diabetes revealed significant differences between the area under the receiver-operating characteristic curve with waist circumference alone and that for the combination of waist circumference with lung capacity measures.
Pulmonary function is lower in people with metabolic syndrome and Type 2 diabetes. Spirometry variables are independent predictors of metabolic syndrome and Type 2 diabetes.
研究肺功能与代谢综合征/2 型糖尿病之间的关系。
共有 1454 名来自澳大利亚维多利亚州农村的成年人参与了横断面研究,他们来自随机选择的家庭,提供了包括肺活量、1 秒用力呼气量、1 秒用力呼气量预计百分比和肺活量预计百分比在内的肺功能测量值。评估还包括 HbA(1c)、代谢综合征成分和 75g 口服葡萄糖耐量试验。比较了腰围的受试者工作特征曲线下面积与腰围和原始肺功能测量值(肺活量和 1 秒用力呼气量)组合的曲线下面积,以识别代谢综合征或 2 型糖尿病。
有更多代谢综合征成分的参与者更有可能出现肺功能下降,尤其是当存在 2 型糖尿病时:有 2-4 个代谢综合征成分的参与者 1 秒用力呼气量预计值下降 5-6%,有 2 型糖尿病的参与者下降 9%。代谢综合征或 2 型糖尿病的风险与更高的肺功能测量值呈负相关(1 秒用力呼气量预计值百分比:女性有 2-4 个代谢综合征成分的比值比为 0.36-0.21,男性为 0.32-0.30;女性 2 型糖尿病的比值比为 0.36,男性为 0.28)。识别代谢综合征和 2 型糖尿病的受试者工作特征曲线分析显示,仅腰围与腰围与肺活量测量值组合的曲线下面积之间存在显著差异。
代谢综合征和 2 型糖尿病患者的肺功能较低。肺功能测量值是代谢综合征和 2 型糖尿病的独立预测指标。